Acuity Functional Impact and Implementation Outcomes Evaluation
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Acuity.
- Who it may be relevant to
- Registry conditions: Autism. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study will test feature enhancements to a behavioral therapy data collection software (Motivity) that will add a new clinical decision support module, called Acuity. Acuity is a Quality Improvement (QI) intervention targeted at Behavior Analysts (BAs) and Behavior Technicians (BTs) that aims to improve the delivery of autism behavioral therapy. Subjects will be staff recruited from existing Motivity customers.
Detailed description
Acuity is intended to provide significant improvements in treatment planning, progress tracking, trend monitoring, and dosage management. If successful, Acuity will provide Applied Behavior Analysis (ABA) practitioners with a higher level of real-time insight into their clinical data, enabling more efficient and productive treatment. Research has shown that first-generation systems fall short in supporting overworked BAs who are overwhelmed with data. Acuity will address critical shortfalls by enabling more agile corrective actions and data-driven planning across multiple aspects of treatment, providing practitioners with new levels of rigorous, real-time insight into their clinical data. Acuity will help BAs establish and adhere to realistic treatment timelines, and will proactively alert the BA to noteworthy trends in the data as they occur, such as learner performance issues, missed dosages, and significant changes in tracked behaviors. In doing so, Acuity will support more responsive and effective treatment.
Interventions
- Behavioral Acuity
Enhancement to Motivity product for clinical decision support
Primary outcome measures
- Number of participants with improved estimation of Trials to Criterion and Time (days) to Criterion [Time frame: through study completion, expected to be 18 months from the start of retroactive observation period]
- Increased frequency of changes to programs and prescribed dosages, resulting in reduced Trials to Criterion and Time to Criterion. [Time frame: through study completion, expected to be 18 months from the start of retroactive observation period]
- Increased adherence to prescribed dosage [Time frame: through study completion, expected to be 18 months from the start of retroactive observation period]
- Number of participants who find Acuity and its components practical and possible to use, assessed by qualitative measures and system usage tracking [Time frame: at the end of the study, expected to be 18 months from the start of retroactive observation period]
- Proportion of clinics and providers that actively use Acuity, assessed by system usage tracking. [Time frame: at the end of the study, expected to be 18 months from the start of retroactive observation period]
- Number of BAs & BTs who utilize Acuity as intended to provide learners with accurate treatment plans, and achieve expected results, as measured by system usage and qualitative assessment. [Time frame: at the end of the study, expected to be 18 months from the start of retroactive observation period]
- Majority of BAs and BTs rate Acuity and its components as attractive, agreeable, or palatable. [Time frame: at the end of the study, expected to be 18 months from the start of retroactive observation period]
- Frequency at which Acuity and its components are rated as suitable, fitting, or proper for achieving the goals set forth in treatment plans, as measured by surveys. [Time frame: at the end of the study, expected to be 18 months from the start of retroactive observation period]
Eligibility criteria
Inclusion criteria
- Behavior Analysts and Behavior Technicians treating kids with autism
- Must be employed by one of the autism treatment clinics that have agreed to participate in the study.
- Must be employed by Experiad customers who are using Motivity software as part of their practice.
Exclusion criteria
- All people not listed above
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Other
Study locations
United States · 1 center
- Experiad LLC — Honolulu
Identifiers
NCT: NCT06561581 · Acuity-Study-1